Patents : |  |
| US Patent No. | Title |
| 7381800 | Antibodies to HBIMF63 polypeptide
|
| 7405237 | Isoindoline compounds and methods of their use
|
| 7407967 | Cyclopamine analogues and methods of use thereof
|
| 7407985 | Compounds that abrogate DNA damage induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments
|
| 7408041 | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
|
| 7410642 | Assays and therapies for latent viral infection
|
| 7411051 | Antibodies to HDPPA04 polypeptide
|
| 7411054 | 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
|
| 7413737 | Anti-hydroxylase antibodies and uses thereof
|
| 7413903 | Methods of regulating differentiation in stem cells
|
| 7414122 | Nucleic acids encoding B7-Like molecules and uses thereof
|
| 7405227 | Treatment of cancer
|
| 7405226 | Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
|
| 7405041 | Methods for regulating transcription by targeting quadruplex DNA
|
| 7385036 | Human tango 509 polypeptides
|
| 7387900 | Colloidal metal compositions and methods
|
| 7388016 | Dibenzonaphthyridine derivatives and methods of use thereof
|
| 7390637 | Keratinocyte derived interferon
|
| 7390799 | Apoptosis promoters
|
| 7390888 | Dendritic cell potentiation
|
| 7393534 | Compositions and methods for immunotherapy of cancer and infectious diseases
|
| 7393862 | Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
|
| 7399633 | Methods for immortalizing cells
|
| 7402579 | Quinobenzoxazine analogs and compositions
|
| 7417121 | Human G-protein coupled receptor, HGPRBMY39
|
| 7422741 | VEGFR-3 fusion proteins
|
| 7435796 | Antibodies which bind B7RP1
|
| 7435803 | Anti-CD20 antibodies and fusion proteins thereof and methods of use
|
| 7435808 | Polynucleotides encoding novel adiponectin receptor variant, AdipoR2v2
|
| 7439224 | Indications of mannan-binding lectin (MBL) in the treatment of immuno-compromised individuals
|
| 7442830 | Proteasome inhibitors
|
| 7445780 | Antagonistic anti-CD40 antibodies
|
| 7446176 | 12 human secreted proteins
|
| 7446178 | Antibodies that recognize hyperproliferative cells and methods of making and using same
|
| 7449557 | Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
|
| 7452538 | Death domain containing receptor 4 antibodies and methods
|
| 7435755 | CDDO-compounds and combination therapies thereof
|
| 7435412 | Chronic lymphocytic leukemia cell line
|
| 7432369 | Pyridyl-substituted porphyrin compounds and methods of use thereof
|
| 7422899 | Antibodies to the human prolactin receptor
|
| 7423116 | Pentapeptide compounds and uses related thereto
|
| 7425553 | Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
|
| 7425619 | Fc.gamma.RIIB specific antibodies and methods of use thereof
|
| 7425620 | Fc.gamma.RIIB-specific antibodies and methods of use thereof
|
| 7427605 | Inhibitors of ribonucleotide reductase subunit 2 and uses thereof
|
| 7427665 | Chronic lymphocytic leukemia cell line
|
| 7429595 | Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
|
| 7429646 | Antibodies to human tumor necrosis factor receptor-like 2
|
| 7432244 | Method of inhibiting insulin-like growth factor-1 (IGF-1) by IGF-1-antagonist peptides
|
| 7456256 | BGS 4
|
